Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Treasury Shares (2025)

CG Oncology (CGON) has disclosed Treasury Shares for 1 consecutive years, with $166342.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed N/A year-over-year to $166342.0, compared with a TTM value of $166342.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $166342.0, changed N/A over the prior year.
  • Treasury Shares was $166342.0 for Q4 2025 at CG Oncology, up from $94624.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $166342.0 in Q4 2025 and bottomed at $94624.0 in Q3 2025.